Details for New Drug Application (NDA): 215577
✉ Email this page to a colleague
The generic ingredient in PREGABALIN is pregabalin. There are forty-one drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the pregabalin profile page.
Summary for 215577
Tradename: | PREGABALIN |
Applicant: | Zydus Pharms |
Ingredient: | pregabalin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215577
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 82.5MG | ||||
Approval Date: | Aug 26, 2022 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 165MG | ||||
Approval Date: | Aug 26, 2022 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 330MG | ||||
Approval Date: | Aug 26, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription